drugset / Trial / NCT00512486
A Sequential Dose-Escalation Study in Subjects With Mild Asthma
Non-randomizedSingle-groupOpen-label
Summary
The primary objective of this study is to investigate the safety of administration of this drug by increasing doses to male and female adult subjects with mild asthma.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Benralizumab | Monoclonal antibody | 0.0003 mg/kg | Intravenous |
| Comparator | Benralizumab | Monoclonal antibody | 0.003 mg/kg | Intravenous |
| Comparator | Benralizumab | Monoclonal antibody | 0.03 mg/kg | Intravenous |
| Comparator | Benralizumab | Monoclonal antibody | 0.1 mg/kg | Intravenous |
| Comparator | Benralizumab | Monoclonal antibody | 0.3 mg/kg | Intravenous |
| Comparator | Benralizumab | Monoclonal antibody | 1 mg/kg | Intravenous |
| Comparator | Benralizumab | Monoclonal antibody | 3 mg/kg | Intravenous |